News for Invitae Corporation (NVTA)

With rising chronic disease rates and increasing collaboration between pharmaceutical companies and academia, the nanomedicine market is poised for...

Baird boosts Laboratory Corporation of America stock target, retains Outperform

PRESS RELEASE - 13/08/2024, 16:00 CEST Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer...

Labcorp's expansive test portfolio and recent acquisitions bolster its market position.Legal challenges and regulatory scrutiny pose potential risks to operati

Labcorp beats Q2 profit and revenue estimates on demand for health tests

We recently compiled a list of the 10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood.

The Global Precision Oncology Market Size was Valued at USD 98.5 Billion in 2023 and the Worldwide Precision Oncology Market Size is Expected to Reach USD...

New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines

Earnings call: GeneDx reports 51% revenue surge, eyes profitability by 2025

Labcorp Announces Winning Bid for Select Assets of Invitae

Labcorp to acquire Invitae assets for $239 million

– Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantially All of the...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Hereditary Cancer...

Invitae gets court approval for five-month bankruptcy sale

PALM BEACH, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will...

Genomic cancer testing is a medical diagnostic process that involves analyzing the DNA of cancer cells to identify specific mutations, rearrangements, or...

Investors are optimistic as we move into the third quarter earnings season.

/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics by Application, Technology and Funding With Executive and Consultant Guides...

Rising demand for direct-to-consumer genetic testing for developing personalized medicine specifically targeted to individuals is one of the major factors...